H. pylori-related disease
The most important modifiable risk factor. Long-standing infection causes inflammation that progresses to cancer over years. Testing and treating H. pylori reduces risk.
Stomach Cancer Treatment in Hyderabad
Stomach cancer is often diagnosed late in India because early symptoms mimic common indigestion. Dr. Madhav Danthala provides treatment planning, chemotherapy, targeted therapy, and immunotherapy at Omega Hospitals, Gachibowli, and Peoples Polyclinic, Manikonda.
What is Stomach Cancer?
Most stomach cancers are adenocarcinomas — arising from the lining of the stomach. Modern care is shaped by molecular profile.
HER2-positive gastric cancer
About 15-20% of cases over-express HER2. These respond well to anti-HER2 targeted therapy (trastuzumab) added to chemotherapy.
CLDN18.2 / MSI / PD-L1
Newer biomarkers — Claudin 18.2, microsatellite instability, PD-L1 — guide targeted therapy and immunotherapy choices.
When to See a Doctor
Most cases of indigestion are benign. The pattern that matters is when symptoms are new, persistent, or accompanied by other warning signs.
Persistent indigestion
Indigestion or heartburn lasting more than three weeks, especially in anyone over 45.
Feeling full quickly
Loss of appetite or feeling full after very small meals — early satiety.
Unexplained weight loss
More than 5 kg lost in a few months without dietary or activity change.
Iron-deficiency anaemia
Unexplained low haemoglobin warrants upper GI endoscopy alongside colonoscopy.
Dr. Danthala's Approach
Gastric cancer treatment in 2026 is increasingly precision-guided.
Molecular profiling first
HER2, MSI, PD-L1, and CLDN18.2 are tested at diagnosis to guide therapy choice and identify candidates for targeted therapy or immunotherapy.
More than one path
For locally advanced gastric cancer, surgery-first vs perioperative chemotherapy vs newer immunotherapy combinations are all defensible — depending on tumour location and patient fitness.
Clear, structured communication
Every consult ends with a written summary of the plan, expected timeline, and the trade-offs each option carries.
Frequently Asked Questions
What are the warning signs of stomach cancer?
Persistent indigestion, feeling full quickly, unexplained weight loss, persistent upper abdominal pain, iron-deficiency anaemia, or difficulty swallowing. Most causes are benign, but persistence — especially over 45 — warrants endoscopic evaluation.
Should I get tested for H. pylori?
H. pylori is the most important modifiable risk factor for stomach cancer. Testing is recommended if you have persistent indigestion, ulcer-like symptoms, family history, or are from a high-prevalence region. Treatment with antibiotics significantly reduces long-term cancer risk.
When should I have an upper GI endoscopy?
Endoscopy is underused in India given how common gastric cancer is. Indications: persistent indigestion, ulcer pain, unexplained weight loss, difficulty swallowing, iron-deficiency anaemia, family history. 20 minutes under sedation, no admission.
What is HER2-positive gastric cancer?
About 15-20% of stomach cancers over-express HER2. These respond well to anti-HER2 targeted therapy (trastuzumab) added to chemotherapy. Every advanced gastric cancer should be HER2-tested at diagnosis.
What does treatment involve?
Early-stage: surgery, often with perioperative chemotherapy. Advanced disease: chemotherapy plus targeted therapy (for HER2-positive or CLDN18.2-positive) or immunotherapy (for PD-L1 positive). Newer agents have significantly improved outcomes recently.
Consult Dr. Madhav Danthala
For first opinion, second opinion, or treatment planning: